Sophie Millar
Sophie Millar completed her doctorate studies in vascular and cannabinoid based medicines at the University of Nottingham, and is currently based in Brussels undertaking a Traineeship at the European Parliament Research Services. She is interested in communicating topics broadly related to drug development and health, and has contributed to a number of STEM outreach activities and articles.-
A scientist’s opinion : Interview with Aroon Hingorani about re-engineering pharmaceutical research
Interview with Aroon Hingorani, Professor of Genetic Epidemiology at University College London about Re-engineering pharmaceutical research. Could you speculate what you think are the biggest causes of drug failure? Aroon Hingorani: It is well recognised that the number one cause for drug failure... -
A scientist’s opinion : Interview with Dr Denis Lacombe about re-engineering pharmaceutical research
Interview with Dr Denis Lacombe, Director General of the European Organisation for Research and Treatment of Cancer (EORTC) about Re-engineering pharmaceutical research. Can you tell me a bit about the European Organisation for Research and Treatment of Cancer (EORTC)? Denis Lacombe: We are a non-governmental,...